These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 12693805)

  • 1. Incidence and prevalence of cryptogenic fibrosing alveolitis in a Norwegian community.
    von Plessen C; Grinde O; Gulsvik A
    Respir Med; 2003 Apr; 97(4):428-35. PubMed ID: 12693805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival in patients with cryptogenic fibrosing alveolitis: a population-based cohort study.
    Hubbard R; Johnston I; Britton J
    Chest; 1998 Feb; 113(2):396-400. PubMed ID: 9498958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Idiopathic pulmonary fibrosis, clinical features in Thai patients.
    Palwatwichai A; Tiyanon W; Chaoprasong C; Vattanathum A; Tantamacharik D
    J Med Assoc Thai; 2000 Oct; 83(10):1248-52. PubMed ID: 11143492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung cancer and cryptogenic fibrosing alveolitis. A population-based cohort study.
    Hubbard R; Venn A; Lewis S; Britton J
    Am J Respir Crit Care Med; 2000 Jan; 161(1):5-8. PubMed ID: 10619790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrosing alveolitis associated with systemic sclerosis has a better prognosis than lone cryptogenic fibrosing alveolitis.
    Wells AU; Cullinan P; Hansell DM; Rubens MB; Black CM; Newman-Taylor AJ; Du Bois RM
    Am J Respir Crit Care Med; 1994 Jun; 149(6):1583-90. PubMed ID: 8004317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cryptogenic fibrosing alveolitis. A study of an indigenous African population.
    Smith C; Feldman C; Levy H; Kallenbach JM; Zwi S
    Respiration; 1990; 57(6):364-71. PubMed ID: 2099570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of cryptogenic fibrosing alveolitis in Moravia and Silesia.
    Kolek V
    Acta Univ Palacki Olomuc Fac Med; 1994; 137():49-50. PubMed ID: 7778506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rising mortality from cryptogenic fibrosing alveolitis.
    Johnston I; Britton J; Kinnear W; Logan R
    BMJ; 1990 Nov; 301(6759):1017-21. PubMed ID: 2249048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional impairment in lone cryptogenic fibrosing alveolitis and fibrosing alveolitis associated with systemic sclerosis: a comparison.
    Wells AU; Hansell DM; Rubens MB; Cailes JB; Black CM; du Bois RM
    Am J Respir Crit Care Med; 1997 May; 155(5):1657-64. PubMed ID: 9154872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cryptogenic fibrosing alveolitis with preserved lung volumes.
    Doherty MJ; Pearson MG; O'Grady EA; Pellegrini V; Calverley PM
    Thorax; 1997 Nov; 52(11):998-1002. PubMed ID: 9487350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exposure to commonly prescribed drugs and the etiology of cryptogenic fibrosing alveolitis: a case-control study.
    Hubbard R; Venn A; Smith C; Cooper M; Johnston I; Britton J
    Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):743-7. PubMed ID: 9517585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha1-antitrypsin phenotypes in patients with cryptogenic fibrosing alveolitis: a case-control study.
    Hubbard R; Baoku Y; Kalsheker N; Britton J; Johnston I
    Eur Respir J; 1997 Dec; 10(12):2881-3. PubMed ID: 9493678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cryptogenic fibrosing alveolitis and the fibrosing alveolitis of systemic sclerosis: morphological differences on computed tomographic scans.
    Chan TY; Hansell DM; Rubens MB; du Bois RM; Wells AU
    Thorax; 1997 Mar; 52(3):265-70. PubMed ID: 9093344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accuracy of diagnostic coding of hospital admissions for cryptogenic fibrosing alveolitis.
    Johnston ID; Bleasdale C; Hind CR; Woodcock AA
    Thorax; 1991 Aug; 46(8):589-91. PubMed ID: 1926030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adult familial cryptogenic fibrosing alveolitis in the United Kingdom.
    Marshall RP; Puddicombe A; Cookson WO; Laurent GJ
    Thorax; 2000 Feb; 55(2):143-6. PubMed ID: 10639533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mediastinal lymphadenopathy in cryptogenic fibrosing alveolitis: the effect of steroid therapy on the prevalence of nodal enlargement.
    Franquet T; Gimenez A; Alegret X; Rodriguez-Arias JM
    Clin Radiol; 1998 Jun; 53(6):435-8. PubMed ID: 9651059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cryptogenic fibrosing alveolitis and lung cancer.
    Turner-Warwick M; Lebowitz M; Burrows B; Johnson A
    Thorax; 1980 Jul; 35(7):496-9. PubMed ID: 7434310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adult height and cryptogenic fibrosing alveolitis: a case-control study using the UK general practice research database.
    Hubbard R; Venn A
    Thorax; 2000 Oct; 55(10):864-6. PubMed ID: 10992540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extrinsic allergic alveolitis: a disease commoner in non-smokers.
    Warren CP
    Thorax; 1977 Oct; 32(5):567-9. PubMed ID: 594937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutrophil activation in fibrosing alveolitis: a comparison of lone cryptogenic fibrosing alveolitis and systemic sclerosis.
    Cailes JB; O'Connor C; Pantelidis P; Southcott AM; Fitzgerald MX; Black CM; du Bois RM
    Eur Respir J; 1996 May; 9(5):992-9. PubMed ID: 8793462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.